Pfizer has urged a US Court of Appeals to uphold a decision to dismiss a lawsuit from an anti-affirmative action group that challenged its diversity fellowship program. The US Court of Appeals for the Second Circuit dismissed Do No Harm’s lawsuit because the group failed to name at least one individual harmed by Pfizer’s program. The lawsuit against Pfizer The case involves Pfizer’s fellowship program aimed at recruiting and training Black, Latine, and Native American leaders. Do No Harm’s lawsuit claims the program violated federal civil rights laws.  In March,